GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharmaceuticals Industries Ltd (NSE:SUNPHARMA) » Definitions » Other Long Term Assets

Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Other Long Term Assets : ₹134,226 Mil (As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Sun Pharmaceuticals Industries Other Long Term Assets?

Sun Pharmaceuticals Industries's other long-term assets for the quarter that ended in Mar. 2024 was ₹134,226 Mil.

Sun Pharmaceuticals Industries's quarterly other long-term assets declined from Sep. 2023 (₹111,782 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹134,226 Mil).

Sun Pharmaceuticals Industries's annual other long-term assets increased from Mar. 2022 (₹110,384 Mil) to Mar. 2023 (₹162,523 Mil) but then declined from Mar. 2023 (₹162,523 Mil) to Mar. 2024 (₹134,226 Mil).


Sun Pharmaceuticals Industries Other Long Term Assets Historical Data

The historical data trend for Sun Pharmaceuticals Industries's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Pharmaceuticals Industries Other Long Term Assets Chart

Sun Pharmaceuticals Industries Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 125,310.50 141,048.40 110,383.50 162,522.97 134,226.40

Sun Pharmaceuticals Industries Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 162,522.97 - 111,782.40 - 134,226.40

Sun Pharmaceuticals Industries Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Business Description

Traded in Other Exchanges
Address
Western Express Highway, Sun House, Plot No. 201 B/1, Goregaon (East), Mumbai, MH, IND, 400 063
Sun Pharmaceuticals Industries Ltd is India's largest generic pharmaceutical manufacturer and the fourth largest in the world. The company's largest markets are the U.S. and India to make up the majority of revenue. The remaining is spread across both emerging and developed markets. In addition to generics, the company also produces and distributes name-brand formulas to specific geographies. It maintains manufacturing and research and development facilities globally to serve its markets but is primarily based in India.

Sun Pharmaceuticals Industries (NSE:SUNPHARMA) Headlines

No Headlines